Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Oct 4 - Oct 9
Engelborghs et al., 2003) or decreased (Granerus et al., 1974) in PD patients
Insulin-like growth factor-binding protein-5 (IGFBP-5) acts as a tumor suppressor by inhibiting angiogenesis
10.1007/978-3-319-60189-2_8 257 TjlveH.HenrikssonJ.TallkvistJ.LarssonB
Evangelia Athanasiou (Aristotle University of Thessaloniki) 278 Possible Uses of Urban Heritage for Social Cohesion The field of heritage faces growing pressures to demonstrate its benefits or contributions as funding declines and the sector is required to conform to results-oriented systems
Devices that are part of the Breakthrough Devices Program, have received FDA marketing authorization for the indication covered by the Breakthrough Devices designation, and meet the other criteria in the regulation can be approved through the quarterly process and announced through that process (81 FR 79655)
Epub 2011/04/05
US$ 29.69
US$ 23.64
US$ 23.35
&srotate=0)
US$ 28.64
US$ 25.30
US$ 25.93
